SIBO is associated with the increased expression of toll-like receptor-4 (TLR4) and secretion of IL-8, which influence the inflammatory pathways involved in the pathogenesis of MASLD and cirrhosis (Ghosh and Jesudian, 2019). Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.